Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precipio Inc 4 Science Park New Haven CT 06511 USA

www.precipiodx.com Employees: 60 P: 203-787-7888

Sector:

Medical

Description:

Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.

Key Statistics

Overview:

Market Capitalization, $K 42,048
Enterprise Value, $K 41,038
Shares Outstanding, K 1,752
Float, K 1,456
% Float 83.10%
Short Interest, K 4
Short Float 0.24%
Days to Cover 1.00
Short Volume Ratio 0.23
% of Insider Shareholders 16.90%
% of Institutional Shareholders 10.45%
Annual Net Income, $ -4,290 K
Last Quarter Sales, $ 6,770 K
Last Quarter Net Income, $ -80 K
EBIT, $ -2,080 K
EBITDA, $ -560 K
3-Year Return 46.34%
5-Year Return -54.20%
5-Year Revenue Growth 492.01%
5-Year Earnings Growth 93.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 11/14/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr -200.00%
EPS Growth vs. Prev Year 88.10%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/22/23

PRPO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.07%
Return-on-Assets % -6.71%
Profit Margin % -23.15%
Debt/Equity 0.01
Price/Sales 1.62
Price/Cash Flow N/A
Price/Book 2.83
Book Value/Share 8.49
Interest Coverage -60.29
60-Month Beta 1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar